- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
The White House withdrew its nomination of Dr. Dave Weldon, a former Florida congressman, shortly before his scheduled appearance before the Senate Health, Education, Labor and Pensions Committee on Thursday. An anonymous White House official has said that Weldon didn't have the votes needed for confirmation by the Senate. Dr. Weldon wrote a four-page statement which was published by The Washington Post and The New York Times.
Big Pharma and the American Public Health Association were opposed to Dr. Weldon because he brought attention to research linking the MMR vaccine and IBD in children.
Jennifer Galardi of the Epoch Times wrote the most complete post mortem of Dr. Weldon's CDC nomination:
https://thefederalist.com/2025/03/14/scuttled-cdc-pick-slams-big-pharma-and-senators-on-its-payroll/
Scuttled CDC Pick Slams Big Pharma And Senators On Its Payroll
By Jennifer Galardi - March 14, 2025In a statement released on the day of his abruptly canceled confirmation hearing, Dr. Dave Weldon, President Trump’s initial nominee to lead the Centers for Disease Control and Prevention, said concerns that Big Pharma was behind the subversion were “probably true.”
“They are hands-down, the most powerful lobby organization in Washington DC giving millions of dollars to politicians on both sides of the aisle,” he wrote.
Weldon said that Wednesday evening, before the morning of his hearing before the Senate Health, Education, Labor, and Pensions (HELP) committee, he had received a call from a White House assistant telling him his nomination had been withdrawn due to a lack of affirmative votes.
According to Weldon’s statement, Health and Human Services Secretary Robert F. Kennedy Jr. told him Sen. Susan Collins of Maine suddenly “had reservations” about confirming him despite having “a very pleasant meeting” with Weldon previously.
“I can assume that the White House staff had my nomination withdrawn also because the Republican Chairman Dr. Bill Cassidy of Louisiana was also voting no,” Weldon wrote.
His claim that “politicians on both sides of the aisle” receive millions of dollars from pharmaceutical companies and lobbyists is undoubtedly true. Pharmaceutical companies spend almost $300 million on lobbying, far outpacing competitors such as the electronics manufacturing industry and insurance companies.
Why might Big Pharma have an interest in pressuring members of Congress to deny Weldon the job? You don’t have to look very far for the answer. Just review the hearings of every health official Trump has nominated to a cabinet position over the past month or so and count how many times “anti-vax” is said.
As a congressman from Florida 25 years ago, Weldon had the “temerity,” as he said in his letter, to question the pharmaceutical companies on what he called two “critical childhood vaccine safety issues.” Weldon said he, like Kennedy, had been approached by hundreds of parents insisting that vaccines had caused injuries, including autism, to their children. Back then, the concern was over a mercury-based preservative in the vaccines known as thimerosal, which is considered a neurotoxin.
Eventually the CDC and pharmaceutical companies agreed to remove thimerosal, though the preservative is still allowed in small amounts in some flu vaccines. The AI overview that pops up in a Google search claims “Extensive scientific research … has concluded that there is no credible evidence linking thimerosal to autism or other neurodevelopmental disorders.” Could it be because the major scientific and medical bodies were incentivized not to find credible evidence?
Weldon asserted that when the “CDC ended up publishing a research study claiming the mercury had done no harm,” there were “credible accusations that CDC had incorrectly manipulated the data to exonerate themselves.”
Weldon also took on the MMR (measles, mumps, rubella) shot, according to his letter, after coming across research by British pediatric gastroenterologist Andrew Wakefield suggesting that many children had suffered a form of inflammatory bowel disease upon taking the MMR shot.
Wakefield sent samples to Irish virologist John O’Leary, “who was able to show … that the inflammatory bowel disease biopsies in these children contained the vaccine strain measles viruses,” Weldon wrote. The theory was that it “also might have been affecting their central nervous system and causing the autistic features.”
Measles cases rose after parents became hesitant to give their kids the MMR shot, due to Wakefield and O’Leary’s research. Essentially, Weldon concluded, O’Leary was pressured to retract his findings and Wakefield lost his medical license.
Weldon believes these two objections killed his shot at being CDC director. He has forever been tarnished as an “anti-vaxxer” despite his insistence that he just wants solid, unbiased research done on the safety of vaccines.
“I have learned the hard way don’t mess with Pharma,” he wrote.
It raises the question: Can Big Pharma be beaten? Can Kennedy and his cohorts at the multiple health agencies really change the way people view health? The entire medical-industrial complex includes not only pharmaceutical companies, but hospitals, insurance companies, and even large food conglomerates, and it propels a good chunk of the American economy.
According to the Census Bureau’s 2019 American Community Survey (ACS), the healthcare industry employs 22 million workers, or 14 percent of the American workforce. Healthcare employment growth is projected to exceed the national average, even though access to primary care physicians is decreasing, suggesting growth in medical bureaucracy and administration rather than direct care providers.
People seem to forget that sickness is a very lucrative business. Pharmaceutical companies, more than any other industry in the medical establishment, are selling you a product. They pressure you to buy — and doctors to sell — their products through commercials, complete with musical dance numbers.
Pharmaceutical companies spend a lot of money researching why people might be hesitant to inject a vaccine into their body, so they can better shut down those concerns. However, according to a report in The Washington Post last week, the NIH will be terminating or limiting grants to fund research related to vaccine hesitancy. It’s a good first step to undoing the propaganda consistently forced down our throats when it comes to so-called healthcare.
Dave Weldon would have been an excellent choice to continue that trend at the CDC. Let’s hope President Trump will find someone equally courageous to follow in his footsteps — someone who can’t be purchased.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















